Related Experiment Videos
Dynamics of target-mediated drug disposition
Lambertus A Peletier1, Johan Gabrielsson
1Mathematical Institute, Leiden University, PB 9512, 2300 RA Leiden, The Netherlands. peletier@math.leidenuniv.nl
Summary
This study mathematically analyzes target-mediated drug disposition (TMDD) models. It provides conditions for simplified model validity and explains how infusion rates affect drug concentration time courses.
Area of Science:
- Pharmacokinetics and Mathematical Modeling
- Drug Metabolism and Disposition Studies
- Systems Biology Approaches
Background:
- Target-mediated drug disposition (TMDD) is a complex pharmacokinetic model.
- Understanding TMDD is crucial for accurate drug development and dosing.
- Existing simplified models (QSS, QE, MM) have limitations in representing TMDD.
Purpose of the Study:
- To provide a rigorous mathematical analysis of the fundamental TMDD model.
- To establish precise conditions for the validity of reduced TMDD models.
- To elucidate the relationship between TMDD model parameters and observed pharmacokinetic profiles.
Main Methods:
- Development of a geometrical description for concentration evolution in TMDD.
- Comparative analysis of the full TMDD model against quasi-steady-state (QSS), quasi-equilibrium (QE), and Michaelis-Menten (MM) models.
- Identification of parameter regimes governing TMDD model behavior and time courses.
Main Results:
- Precise conditions for the validity of QSS, QE, and MM models within the TMDD framework were determined.
- A non-monotone dependence of time-to-steady-state on infusion rate was identified and explained.
- Potential overestimation of central compartment volume due to initial ligand concentration behavior in TMDD was highlighted.
Conclusions:
- The study offers a transparent framework for comparing TMDD models.
- Accurate application of reduced models requires adherence to derived parameter conditions.
- Understanding singular initial behaviors is critical for precise pharmacokinetic parameter estimation in TMDD.
Related Concept Videos
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
278
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
278
01:21Pharmacodynamics: Overview and Principles
2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.1K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.1K
01:15Drug Concentration Versus Time Correlation
2.0K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
2.0K
01:25Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
335
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
335
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
216
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
216